Skip to content

Biomanufacturing Excellence Act of 2025

In committee: it can still change before the session ends.

US HR 6089 · House Bill · 119th Congress

Draft a letter
Stage
In committee
Started in
House
Sponsors
17
Latest action
Nov 18, 2025

What it does

The Biomanufacturing Excellence Act of 2025 would establish a National Biopharmaceutical Center of Excellence under the National Institute of Standards and Technology to advance biopharmaceutical manufacturing, support workforce training, and strengthen U.S. supply chain self-sufficiency. The center would be funded through a competitive grant or other transaction agreement awarded to an eligible non-federal entity, such as a public-private partnership, institution of higher education, or consortium, with $120 million authorized for fiscal year 2026. The bill requires the center to focus on improving manufacturing technologies, supporting good manufacturing practices, advancing workforce…

No official summary is available here. This one was written by AI from the bill’s text.

Read the full textRead it on the official site

Where it stands

  1. Introduced (Done)

    Nov 18, 2025

  2. Committee (Current step)

    In committee · Nov 18, 2025

  3. Floor (Not started)

  4. Law (Not started)

What moved

Loading recorded actions…

Who is involved

Sponsors

The lawmakers who put their names on it, lead sponsors first.

Where it goes next

While a bill can still move, the questions are about people and money.

Work with this bill

Biomanufacturing Excellence Act of 2025 | 52